Aurobindo Pharma Limited has informed the Exchange about press release dated 17-Mar-2022 titled Signing of voluntary license for Pfizer Covid19 oral treatment��� nirmatrelvir
Press Release Mar 17 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Jan 11 2022
- Press Release Dec 28 2021
- Press Release Sep 29 2021
- Press Release Sep 22 2021
- Press Release Aug 27 2021
Later from Aurobindo Pharma
- Press Release May 03 2022
- Press Release May 26 2022
- Press Release Jun 07 2022
- Press Release Jul 06 2022
- Press Release Aug 16 2022
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma